Consistent with these results, other studies also support the working model of mangiferin on neurodegenerative diseases, in which it could ameliorate the neuroinflammatory responses by declining the expression of IL-6 and IL-1β (Feng et al., 2019). The gene discussed is IL6; the disease is neurodegenerative disease.